Clinical studies recruiting near Cary

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Duke Cancer Center Cary · Pfizer · NCT07028853 Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Phase N/A · Duke Cancer Institute Cary · Duke University · NCT04085029 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Duke Cancer Center Cary · NRG Oncology · NCT05624996 A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · Revival Research Institute, LLC · Eli Lilly and Company · NCT06857942 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · North Carolina Retina Associates · Astellas Pharma Global Development, Inc. · NCT06779773 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Duke Cancer Center Cary · NRG Oncology · NCT05174169 Embo Registry; National Registry for Artery Embolization
Phase N/A · Vascular Solutions of North Carolina · Vascular Solutions of North Carolina · NCT06477965 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Duke Cancer Center Cary · Alliance for Clinical Trials in Oncology · NCT06876714 The THOR IDE Study
NA · Vascular Solutions of North Carolina · Philips Clinical & Medical Affairs Global · NCT05916950 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Deg
Phase 3 · Adverum Clinical Site 234 · Adverum Biotechnologies, Inc. · NCT07482176 Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Phase 3 · Revival Research Institute, Llc - Cary, Nc · Sun Pharmaceutical Industries, Inc. · NCT07133308 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · North Carolina Retina Associates (Cary) · Kodiak Sciences Inc · NCT06990399 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Duke Cancer Center Cary · Alliance for Clinical Trials in Oncology · NCT04242095 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Duke Cancer Center Cary · National Cancer Institute (NCI) · NCT05256225 Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescent
Phase 2 · Duke Cancer Center Cary · National Cancer Institute (NCI) · NCT06900595 Drug-Drug Interaction Study of ABP-671 in Gout Patients
Phase 1 · Wakefield Clinical Research · Atom Therapeutics Co., Ltd · NCT07367971 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Duke Cancer Center Cary · National Cancer Institute (NCI) · NCT06498635 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Duke Cancer Center Cary · NRG Oncology · NCT05327686 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · WakeMed Cancer Care - Waverly Hematology & Medical Oncology · Merck Sharp & Dohme LLC · NCT03486873 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Duke Cancer Center Cary · Pfizer · NCT07222800 A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Phase 3 · Accellacare of Cary · Ardelyx · NCT07382167 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 1065 · Anthos Therapeutics, Inc. · NCT05712200 Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macul
Phase 3 · North Carolina Retina Associates · 4D Molecular Therapeutics · NCT07064759 Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Phase 2 · North Carolina Retina Associates · ONL Therapeutics · NCT06659445 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · UNC Health Cancer Care Cary · National Cancer Institute (NCI) · NCT06058377 MagDI U.S. Registry
Phase N/A · Bariatric Specialists of the Carolinas · GT Metabolic Solutions, Inc. · NCT06928545 A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Phase 2 · Cary, North Carolina · EyeBiotech Ltd. · NCT07205887 A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC20172
Phase 2 · Oculus Research - Cary · Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. · NCT07395986 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Duke Cancer Center Cary · National Cancer Institute (NCI) · NCT05987241 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Duke Cancer Center Cary · SWOG Cancer Research Network · NCT04205968

Look up another city

Look up another condition